Skip to main content Accessibility help
×
Home

Lupus Anticoagulant, Antiphospholipid Antibodies and Migraine

  • M.J. Hogan (a1), D.G. Brunet (a1), P.M. Ford (a1) (a2) and D. Lillicrap (a1) (a2)

Abstract:

The records of fifteen patients referred for neurological assessment and found to have lupus anticoagulant or elevated anticardiolipin antibodies were reviewed. The mean age for females in the group was 29.4 years and for males was 35. A diagnosis of migraine, either as an acute or chronic problem, was made in 10 (66%) of these patients. Seven of the 15 patients had ischemic stroke and two patients had other thrombotic complications associated with lupus anticoagulant. Three of the nine female patients with migraine had histories of spontaneous abortions. All migraine patients experienced transient or more prolonged neurological deficits with their headaches. An association between lupus anticoagulant and migraine can only be suggested. Data on the incidence of migraine in patients with lupus anticoagulant in the general medical population does not exist. Furthermore the prevalence of lupus anticoagulant in migraine sufferers is unknown. Therefore further studies are required to investigate this possible association.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Lupus Anticoagulant, Antiphospholipid Antibodies and Migraine
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Lupus Anticoagulant, Antiphospholipid Antibodies and Migraine
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Lupus Anticoagulant, Antiphospholipid Antibodies and Migraine
      Available formats
      ×

Copyright

Corresponding author

c/o EEG Department, Kingston General Hospital, Kingston, Ontario, Canada K7L 2V7

References

Hide All
1.Conley, CL, Hartmann, RC. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. Clin Invest 1952; 31: 621622.
2.Espinoza, LR, Hartmann, RC. Significance of the lupus anticoagulant. Am J Hematol 1986; 22: 331337.
3.Rapaport, SI, Feinstein, DI. Lupus anticoagulant and other hemostatic problems. In: Wallace, DJ, Dubois, EL, eds. Lupus Erythematosus, 3rd Ed. Lea and Febiger 1987: 271280.
4.Schleider, MA, Nachman, RL, Jaffe, EA, et al. A clinical study of the lupus anticoagulant. Blood 1976; 48: 499509.
5.Gastineau, DA, Kazmier, FJ, Nichols, WL, et al. Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 cases. Am J Hematol 1985; 19: 265275.
6.Bowie, EJW, Thompson, JH, Cascuzzi, PA, et al. Thrombosis in SLE despite circulation anticoagulants. J Lab Clin Med 1963; 62: 416430.
7.Elias, M, Eldor, A. Thromboembolism in patients with the “Lupus” - type circulating anticoagulant. Arch Intern Med 1984; 144: 510515.
8.Mueh, JR, Herbst, KD, Rapaport, SI. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980; 92: 156159.
9.Boey, ML, Colaco, CB, Gharavi, AE, et al. Thrombosis in systemic lupus erythematosus: Striking association with the presence of circulating anticoagulant. Br Med J 1983; 287: 10211023.
10.Glueck, HI, Kant, KS, Weiss, MA, et al. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 1985; 145: 13891395.
11.Harris, EN, Gharavi, AE, Boey, ML, et al. Anticardiolipin antibodies: Detection by radioimmunoassay and association with throbosis in systemic lupus erythematosus. Lancet 1983; 2: 12111214.
12.Colaco, CB, Male, DK. Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: Distinct profiles of epitope specificity. Clin Exp Immunol 1985; 59: 449456.
13.Carreras, LO, Defreyn, G, Machin, SJ, et al. Arterial thrombosis, intrauterine death and “lupus” anticoagulant: Detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; 1: 244246.
14.Fisher, M, McGehee, W. Cerebral infarct, TIA, and lupus inhibitor. Neurology 1986; 36: 12341237.
15.Landi, G, Calloni, MV, Sabbadini, MG. Recurrent ischemic attacks in two young adults with lupus anticoagulant. Stroke 1983; 14: 377379.
16.Kelly, RE, Gilman, PB, Kovacs, AG. Cerebral ischemia in the presence of lupus anticoagulant. Arch Neurol 1984; 41: 521523.
17.D’Alton, JG, Preston, DN, Bormanis, J, et al. Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke 1985; 16: 512514.
18.Baker, WH, Potthoff, WP, Biller, J, et al. Carotid artery thrombosis associated with lupus anticoagulant. Surgery 1985; 8: 612615.
19.Tabachnick-Schor, NF, Lipton, SA. Association of lupus like anticoagulant and nonvasculitic cerebral infarction. Arch Neurol 1986; 43: 851852.
20.Levine, SR, Welch, KMA. Cerebrovascular ischemia associated with lupus anticoagulant. Stroke 1987; 18: 257263.
21.Brandt, KD, Lessell, S. Migrainous phenomena in systemic lupus erythematosus. Arthritis Rheum 1978; 21: 716.
22.Levine, SR, Joseph, R, D’Andrea, G, et al. Migraine and the lupus anticoagulant. Case reports and review of the literature. Cephalalgia 1987; 7: 9399.
23.Exner, T, Rickard, KA, Kronenberg, H. A sensitive test demonstrating lupus anticoagulant and its behavioral patterns. Br J Haematol 1978; 40: 143151.
24.Koike, T, Sueshi, M, Funaki, H, et al. Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 1984; 56: 193199.
25.Rose, FC. Headache: Definitions and Classification. In: Rose, FC, ed. Handbook of Clinical Neurology, Vol. 4: Headache. Elsevier Science Publishers 1986; 48: 112.
26.Ad Hoc Committee on Classification of Headache. Classification of headache. JAMA 1962; 179: 127128.
27.Ziegler, DK. The headache symptom. How many entities? Arch Neurol 1985; 42: 273274.
28.Bickerstaff, ER. Basilar artery migraine. Lancet 1961; 1: 1517.
29.Meyer, O, Piette, J, Bourgeois, P, et al. Anti-phospholipid antibodies: A disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus. Comparison with a group of 91 patients with antinuclear antibody positive systemic lupus. J Rheumatol 1987; 14: 502506.

Lupus Anticoagulant, Antiphospholipid Antibodies and Migraine

  • M.J. Hogan (a1), D.G. Brunet (a1), P.M. Ford (a1) (a2) and D. Lillicrap (a1) (a2)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed